2020; Eckel‐Passow et al. 2015; Kikuchi et al. 2020). Our results further support the survival disadvantage associated with TERT promoter mutations in GBM patients. Furthermore, OS showed positive correlation with ADCmin. This evidence concerns the gene TERT and glioblastoma.